Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pedigree analysis of cerebral venous sinus thrombosis associated with compound heterozygous hereditary protein S deficiency.

Annals of hematology·2026

Same author

Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells.

Cell death and differentiation·2026

Same author

Chirality-Induced Spin-Selective Transduction of Circularly Polarized Light for Polarization-Neurochemical Coupling.

ACS nano·2026

Same author

Exploring distributed leadership and proactive change behavior in nursing: the roles of psychological safety and inclusive climate.

Scientific reports·2026

Same author

Design, synthesis and performance evaluation of a fluorescent probe for the detection of sulfur dioxide <i>in vitro</i> and intracellularly.

Analytical methods : advancing methods and applications·2026

Same author

Cunninghamia lanceolata genome illuminates the evolutionary dynamics of gymnosperms.

Cell reports·2026

Same journal

Symptom network analysis in elderly patients with chronic gastritis at two time points: a repeated cross-sectional study.

BMC geriatrics·2026

Same journal

Long-term kidney outcomes after living donation in older adults: clinical findings and equation-dependent eGFR estimates.

BMC geriatrics·2026

Same journal

Comparison of hip abduction range of motion and strength and ankle dorsiflexion in older adults with and without a history of falls.

BMC geriatrics·2026

Same journal

Assessing loneliness in later life: validation of the De Jong Gierveld Loneliness Scale for Portuguese older adults.

BMC geriatrics·2026

Same journal

Geriatric 8 score predicts surgical risk and oncologic outcomes in older patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.

BMC geriatrics·2026

Same journal

Prevalence and determinants of multimorbidity in older Chinese adults: a nationwide cross-sectional study using CLASS data.

BMC geriatrics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 5, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Elevated D-dimer levels after lecanemab infusions: a case report.

Ming Zou¹, Shan-Shan Xu¹, Shi-Guo Zhu¹

¹Department of Neurology and Institute of Geriatric Neurology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

|September 30, 2025

Summary

This summary is machine-generated.

Lecanemab treatment for Alzheimer's disease may cause elevated D-dimer levels, indicating a potential risk for blood clots. Monitoring D-dimer is crucial to manage these adverse drug reactions.

Area of Science:

Neurology
Pharmacology
Immunotherapy

Background:

Lecanemab is an immunotherapy for Alzheimer's disease (AD) that slows cognitive decline.
While effective, its adverse drug reactions require attention.

Keywords:

Adverse drug reactions Alzheimer’s disease Amyloid β D-dimer Lecanemab

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Related Experiment Videos

Last Updated: May 5, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019